Abstract
The appearance of antibiotic resistant strains of Pseudomonas aeruginosa especially pan-drug resistant (PDR) strains has caused efforts to identify alternative antibacterial methods such as phage therapy. The purposes of this study were the isolation and preparing of effective phage cocktails against antibiotic resistant strains of P.aeruginosa. Determination of acquired resistance profiles of these isolates was performed according to new definition of CDC and European Centre for Disease Prevention and Control as multidrug-resistant (MDR), extended-drug resistant (XDR) and PDR, and data were analyzed using WHONET5.6 software. The MDR, XDR, and PDR isolates were selected for finding of their specific bacteriophages from waste waters and hospital sewages. After phage investigation by plaque formation, enrichment, and staining of samples, transmission electron microscopy (TEM) microscope was used for phage morphology and their size determination. Among 96 isolates of P.aeruginosa, 2 (2.1%), 94 (97.9%), 63 (65.6%), and 1 (1.1%) isolates were non-MDR, MDR, XDR, and PDR, respectively. In addition, these 96 strains were in 38 different resistotypes including two non-MDR patterns and 36 MDR patterns that 14 patterns of them belonged to XDR and one pattern corresponded to PDR. In addition, effective antibiotics were polymyxin B, colistin, and fosfomycin and high antibiotic resistance were observed among other antibiotics. The phage cocktails of P.aeruginosa phages was isolated that had extended host range activity against all MDR, XDR, and PDR strains. According to TEM data, three bacteriophages belonging to Cystoviridae, Leviviridae, and Inoviridae families were identified. Phage cocktails used in this study with broad spectrum activity can be as a good alternative of antibiotics against antibiotic resistant strains of P.aeruginosa.
Similar content being viewed by others
References
Ackermann H (2007) 5500 phages examined in the electron microscope. Arch Virol 152(2):227–243
Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, Peck KR (2011) High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 184(12):1409–1417
Cockerill PA (2012) Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standard M2–A9, Clinical and Laboratory Standards Institute
Dash M, Padhi S, Narasimham MV, Pattnaik S (2014) Antimicrobial resistance pattern of Pseudomonas aeruginosa isolated from various clinical samples in a tertiary care hospital, South Odisha, India. Saudi J Health Sci 3:15–19
Delfan AS, Etemadifar Z, Bouzari M, Emtiazi G (2012) Screening of novel bacteriophage infection in Pseudomonas putida isolated from potato disease. Jundi J Microbiol 5(4):550–554
Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D (2010) Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot 63(8):423–430
Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54(1):397–404
Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R et al (2011) Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa. J Coll Physicians Surg Pak 21:531–534
Gomila M, Carmen M, Fernández-Baca V, Pareja A, Pascual M, Díaz-Antolín P, Lalucat J (2013) Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain. BMC Microbiol 13(1):138
Inal JM (2003) Phage therapy: a reappraisal of bacteriophages as antibiotics. Archivum immunologiae et therapiae experimentalis-english edition 51(4):237–244
King AM, Adams MJ, Lefkowitz EJ, Carstens EB (2012) Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses, Elsevier. vol 9
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281
Martinez JL, Baquero F (2002) Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 15(4):647–679
Merabishvili M, Pirnay J-P, Verbeken G et al (2009) Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS One 4(3):4944–4949
Mohanasoundaram KM (2011) The antimicrobial resistance pattern in the clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital; 2008-2010 (a 3 year study). J Clin Diagn Res 5:491–494
Mulet X, Cabot G, Ocampo-Sosa AA, Domínguez MA, Zamorano L, Juan C, Oliver A (2013) Biological markers of Pseudomonas aeruginosa epidemic high-risk clones. Antimicrob Agents Chemother 57(11):5527–5535
Ryan EM, Gorman SP, Donnelly RF, Gilmore BF (2011) Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol 63(10):1253–1264
Shokri D, Zaghian S, Khodabakhsh F, Fazeli H, Mobasherizadeh S, Ataei B (2014) Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains. J Microbiol Immunol Infect 5(47):371–376
Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A (1987) Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986. Arch Immunol Ther Exp 35(5):569–583
Webb JS, Lau M, Kjelleberg S (2004) Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. J Bacteriol 186(23):8066–8073
Acknowledgements
The authors are grateful to Afsaneh Shokri and Fatemeh Khodabakhsh for their valuable help in paper editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical approval
This article does not take in any studies with human participants and animals performed by any of the authors.
Funding
This article did not receive any specific grant.
Rights and permissions
About this article
Cite this article
Shokri, D., Soleimani-Delfan, A. & Fatemi, S.M. Assessment of phage cocktails with extended host range activity against antibiotic resistant strains of Pseudomonas aeruginosa . Comp Clin Pathol 26, 417–422 (2017). https://doi.org/10.1007/s00580-016-2394-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-016-2394-y